Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5000 Target Snapshot

Prostaglandin F2-alpha receptor · SINGLE PROTEIN · Mus musculus

85Compounds
33Assays
1Approved Drugs
41.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P43117. Use UniProt P43117 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P43117 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Prostaglandin F2-alpha receptor as ChEMBL target CHEMBL5000, mapped to UniProt P43117. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Prostaglandin F2-alpha receptor
SINGLE PROTEIN · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL5000
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P43117
Prostaglandin F2-alpha receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Prostaglandin F2-alpha receptor is the right protein anchor across sources, using UniProt P43117 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProstaglandin F2-alpha receptor
UniProt AccessionP43117
Component TypeProtein
Sequence Length366 aa

Prostaglandin F2-alpha receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Prostaglandin F2-alpha receptor, mapped to UniProt P43117. Sequence length is 366 aa.

Mapped IDP43117
Review nameProstaglandin F2-alpha receptor
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC504.0
KI17.0
EC5020.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL491667 8.72 EC50 1.9 Preclinical
CHEMBL4643852 8.3 IC50 5.0 Preclinical
CHEMBL521964 8.24 EC50 5.7 Preclinical
CHEMBL1050 8.2 EC50 6.31 Preclinical
CHEMBL815 7.9 EC50 12.59 Approved
CHEMBL1910324 7.89 IC50 13.0 Preclinical
CHEMBL491474 7.28 EC50 52.4 Preclinical
CHEMBL489109 7.21 EC50 62.2 Preclinical
CHEMBL491475 7.16 EC50 68.6 Preclinical
CHEMBL523143 6.53 EC50 294.0 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
10
5.5
0
6.0
1
6.5
3
7.0
6
7.5
3
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

DINOPROST
CHEMBL815
Approved 1982
Assay Landscape

Assay Landscape

33
Total Assays
11
Tested Compounds
2
Assay Types
Binding — 26 assays, 10 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 18 0
cell-based format 5 9 6.1
single protein format 3 1 8.3
Functional — 7 assays, 11 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 4 10 7.3
assay format 3 1 7.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine